Clinical Significance of Lnc-Ac145676.2.1-6 and Lnc-Tgs1-1 and Their Variants in Western Chinese Tuberculosis Patients.

Hao Bai,Qian Wu,Xuejiao Hu,Tao Wu,Jiajia Song,Tangyuheng Liu,Zirui Meng,Mengyuan Lv,Xiaojun Lu,Xuerong Chen,Yanhong Zhou,Binwu Ying
DOI: https://doi.org/10.1016/j.ijid.2019.04.018
IF: 12.073
2019-01-01
International Journal of Infectious Diseases
Abstract:Objectives: Tuberculosis (TB) remains a global public health problem. Recent studies have implicated long non-coding RNAs and their variants as possibly playing important roles in TB. The aim of this study was to assess the clinical relevance of lnc-AC145676.2.1-6 and lnc-TGS1-1 and their variants in a western Chinese population. Methods: This case-control study included 467 TB patients and 473 healthy controls from West China Hospital. The expression levels of lnc-AC145676.2.1-6 and lnc-TGS1-1 were analyzed by reverse transcriptase quantitative real-time PCR. Single-nucleotide polymorphism genotyping was performed using a custom-designed 2 x 48-Plex SNPscan kit. Results: It was observed that lnc-AC145676.2.1-6 and lnc-TGS1-1 expression levels were both obviously down-regulated in TB patients. In addition, a lower expression level of lnc-TGS1-1 was associated with the presence of thrombocytopenia in TB patients during anti-TB treatment, and the homozygous CC genotype of rs4737420 correlated with a decreased risk of leukopenia, compared with individuals with the T allele (TT/CT genotype), in the dominant mode. Conclusions: For the first time, potential TB-associated promoting effects were identified for the decreased expression levels of lnc-AC145676.2.1-6 and lnc-TGS-1, while lnc-TGS1-1 and its variant rs4737420 may be predictive indicators of anti-TB drug-induced adverse drug reactions. Larger validation studies on different populations are warranted to confirm these findings. (C) 2019 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
What problem does this paper attempt to address?